10:50am ET
Health and Healthcare
Why One Old Stock Buyback Trick Is Working So Well for AbbVie
AbbVie is trying one of the older and less-used efforts to drive its share price back up: a modified Dutch tender auction.
Jon C. Ogg
Companies
/Healthcare
Abbvie Inc
$262.90
▼ $2.89 (−1.09%) today
Markets closed · 12:23am ET
ABBV Coverage
Page 25 Jon C. Ogg 8:35am ET
Health and Healthcare
Short Sellers Grow More Selective on Major Pharma Stocks
The April 13 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
10:15am ET
Health and Healthcare
Eli Lilly, Amgen and More Big Pharma Earnings to Look For This Week
24/7 Wall St. has put together a preview of AbbVie, Eli Lilly and some of the other top pharma and biotech companies reporting their latest quarterly results in the coming week.
11:35am ET
Health and Healthcare
Will a Recent Rheumatoid Arthritis Drug Approval See Rekindled Interest?
Rheumatoid arthritis is an autoimmune disease that attacks tissues within the joints, and it is a major target of U.S. and foreign biotechnology and pharmaceutical companies.
8:30am ET
Health and Healthcare
The Major Pharma Stocks That Are Making Short Sellers Sick
The March 29 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
8:45am ET
Health and Healthcare
Which Major Pharma Stocks Short Sellers Are Keen On
The March 15 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
4:08pm ET
Investing
Monday’s Biggest Winners and Losers in the S&P 500
Monday was an incredible day for the broad U.S. markets, with the Dow posting one of its top 3 performances, in terms of points, in the history of the average. The S&P…
8:25am ET
Health and Healthcare
How Analysts See AbbVie After the Big Disappointment
AbbVie shares took a big step back last week after the firm reported less than favorable results for its relapsed/refractory small cell lung cancer trial.
Chris Lange 9:10am ET
Investing
Top Analyst Upgrades and Downgrades: AbbVie, American Water, Carnival, Cisco, Darden, DexCom, Micron, Nike, Occidental Petroleum and More
The top analyst upgrades, downgrades and other research calls from Friday include AbbVie, American Water, Carnival, Cisco, Darden, DexCom, Micron Technology, Nike and Occidental Petroleum.
4:08pm ET
Investing
Thursday’s Biggest Winners and Losers in the S&P 500
Thursday was an absolute disaster for the broad U.S. markets. There didn’t seem to be anything positive about Thursday for any of the major indices. The Dow was the biggest loser of…
11:50am ET
Health and Healthcare
AbbVie Slides on Weak Midstage Results
AbbVie saw its shares pull back on Thursday after it reported less than favorable midstage results for its relapsed/refractory small cell lung cancer trial.
Chris Lange 10:05am ET
Investing
Jefferies Adds Red-Hot Retail Stock to Franchise Picks List
Jefferies has made a big move by adding a top retail company to its well-respected Franchise Picks list of stocks to Buy.
8:35am ET
Health and Healthcare
Major Pharma Sees Big Drop in Short Interest
The February 28 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
9:10am ET
Health and Healthcare
Short Sellers Hike Bets in Major Pharma
The February 15 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical stocks increased.
8:40am ET
Investing
Jefferies Has 5 Stocks to Buy That Should Raise Dividends and Earnings
These five stocks come with upward earnings revisions and the potential for rising dividends. They all make good sense for investors looking for stocks ideas as we get closer to the second…